List of works by Kaj Blennow

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

scientific article published on 26 February 2010

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

scientific article published on 25 July 2017

1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France

article

24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

scientific article published on 30 October 2017

37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden

scientific article

A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older

scientific article published on 01 January 2018

A 9-year prospective population-based study on the association between the APOE*E4 allele and late-life depression in Sweden

scientific article published on 29 January 2015

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease

scientific article

A Novel ELISA for the Measurement of Cerebrospinal Fluid SNAP-25 in Patients with Alzheimer's Disease

scientific article published on 05 December 2018

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

scientific article

A Practical Guide to Immunoassay Method Validation

scientific article

A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood

scientific article

A Season of American Football Is Not Associated with Changes in Plasma Tau.

scientific article published on 14 June 2017

A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury

scientific article published on 19 June 2019

A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity

scientific article published on 14 September 2004

A common challenge in older adults: Classification, overlap, and therapy of depression and dementia

scientific article published on 28 September 2016

A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease

scientific article published on 23 February 2019

A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.

scientific article published on 14 January 2008

A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease

scientific article published on 29 May 2020

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

scientific article published on 18 December 2019

A multi-center study of neurofilament assay reliability and inter-laboratory variability

scientific article published on 19 June 2020

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.

scientific article published on 23 January 2018

A new procedure for detecting brain-specific proteins in cerebrospinal fluid

scientific article published on 01 January 1997

A new putative principle for diagnosis of Creutzfeldt-Jakob disease

scientific article published in May 2002

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica

A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease

scientific article published on 25 May 2012

A novel ARC polymorphism is associated with reduced risk of Alzheimer's disease

scholarly article by Petronella Kettunen et al published July 2010 in Alzheimer's and Dementia

A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease

scientific article

A novel pathway for amyloid precursor protein processing

scientific article

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease

scientific article published on 17 October 2017

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

scientific article

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

scientific article

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

scientific article published on 8 December 2017

A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality

scientific article

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia

scientific article published in April 1998

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

scientific article published in December 1995

A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease

scientific article published on 01 November 1999

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.

scientific article published in January 2013

A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans

scientific article published on 7 March 2016

A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals

scientific article

A survey of ABCA1 sequence variation confirms association with dementia

scientific article published on September 2009

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

scientific article

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

scientific article

ALCOHOLICS WITH THE DOPAMINE RECEPTOR DRD2 A1 ALLELE HAVE LOWER PLATELET MONOAMINE OXIDASE-B ACTIVITY THAN THOSE WITH THE A2 ALLELE: A PRELIMINARY STUDY

scientific article published on 01 September 2000

APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment

scientific article

APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

scientific article published in June 2004

APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease

scientific article published on 16 June 2016

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

scientific article published on 27 May 2020

APOE-ε4 Shapes the Cerebral Organization in Cognitively Intact Individuals as Reflected by Structural Gray Matter Networks

scientific article published on 12 March 2020

APP metabolism regulates tau proteostasis in human cerebral cortex neurons

scientific article published on 23 April 2015

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia

scientific article published in PLoS ONE

Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

scientific article published on March 2016

Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

scientific article

Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons

scientific article published on 17 January 2020

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

scientific article published in November 2012

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

scientific article

Accuracy of cerebrospinal fluid Aβ1-42 measurements: evaluation of pre-analytical factors using a novel Elecsys immunosassay

scientific article published on 4 February 2017

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

scholarly article by Sebastian Palmqvist et al published 23 October 2018 in Alzheimer's and Dementia

Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers

scientific article

Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs

scientific article published on January 2010

Acute symptomatic seizures and epilepsy after mechanical thrombectomy

scientific article published on 13 September 2019

Additional evidence for antagonistic pleiotropic effects of APOE

scientific article published on 01 January 2009

Admission Levels of Total Tau and β-Amyloid Isoforms 1-40 and 1-42 in Predicting the Outcome of Mild Traumatic Brain Injury

scientific article published on 13 May 2020

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

scientific article

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

scientific article (publication date: September 2012)

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

scientific article

Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology

scientific article published on 01 January 2019

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

scientific article published on 20 August 2020

Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid

scientific article published on 9 March 2018

Agitation in dementia: relation to core cerebrospinal fluid biomarker levels

scientific article

Alterations in the Balance of Amyloid-β Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients

scientific article

Altered blood-brain-barrier function in Alzheimer's disease?

scientific article

Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome

scientific article published on 18 April 2014

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

scientific article published on 6 November 2012

Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease

scientific article published on 10 May 2012

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

scientific article (publication date: March 2004)

Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease.

scientific article published on April 2003

Altered thalamic membrane phospholipids in schizophrenia: a postmortem study

scientific article

Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard

scientific article published on 25 January 2013

Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate

scientific article published on 8 May 2017

Alzheimer's disease

scientific article (publication date: 29 July 2006)

Alzheimer's disease

scientific article

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.

scientific article published on 9 January 2018

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

scientific article

Alzheimer's disease markers in the aged sheep (Ovis aries).

scientific article

Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly

scientific article

Alzheimer's disease--Recent biomarker developments in relation to updated diagnostic criteria

scientific article

Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies

scientific article

Alzheimer's disease: No effect of the CDK5 gene on CSF biomarkers, neuropathology or disease risk

scientific article published on 01 November 2009

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase

scholarly article by Bruno Becker published in August 2018

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment

scientific article

Amyloid and Tau Biomarkers in CSF.

scientific article

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

scientific article

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury

scientific article

Amyloid beta and APP as biomarkers for Alzheimer's disease

scientific article published on 19 August 2009

Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization

scientific article published on April 2008

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

scientific article published on 23 June 2020

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

scientific article

Amyloid biomarkers in Alzheimer's disease

scientific article published on April 2015

Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus

scientific article published on 29 July 2016

Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease

scientific article published on 20 November 2017

Amyloid precursor like protein 1 in Idiopathic Normal Pressure hydrocephalus; expanding the knowledge of an altered amyloid metabolism.

scientific article published on 18 September 2015

Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation

scientific article

Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death

scientific article published on 10 April 2019

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

scientific article published on 27 August 2011

Amyloid-β associated volume loss occurs only in the presence of phospho-tau

scientific article

Amyloid-β metabolism in Niemann-Pick C disease models and patients

scientific article

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease

scientific article published in January 2012

Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease

scientific article published on January 2012

Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment

scientific article published on January 2011

An 18-year follow-up of overweight and risk of Alzheimer disease

scientific article

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid

scientific article

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease

scientific article published on 22 December 2014

An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid

scientific article published in May 2012

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

scientific article published on 22 April 2020

An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead

scientific article published on 12 December 2019

Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis

scientific article

Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk

scientific article

Analysis of proteins from a glioma cell line by using micro-scale solution isoelectric focusing in combination with liquid chromatography/tandem mass spectrometry

scientific article

Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method

scientific article published on 01 April 2020

Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies

scientific article published in January 2006

Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803-810 (2014).

scientific article

Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

scientific article

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment

scientific article

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

scientific article published in October 2014

Apolipoprotein E genotypes and longevity across dementia disorders.

scientific article published on 13 March 2018

Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.

scientific article published in September 1996

Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions

scientific article

Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury

scientific article published in November 2008

Apolipoprotein E polymorphism in aneurysmal subarachnoid haemorrhage in West Sweden

scientific article published on 16 September 2015

Apolipoprotein E polymorphism in patients with cataract

scientific article published on May 2004

Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.

scientific article

Aspects of beta-amyloid as a biomarker for Alzheimer's disease

scientific article published on June 2007

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

article

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

scientific article published on 01 July 2019

Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years

scientific article published on 04 October 2016

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

scientific article published on March 2006

Association between change in normal appearing white matter metabolites and intrathecal inflammation in natalizumab-treated multiple sclerosis

scientific article

Association between thyroid hormone levels and monoaminergic neurotransmission during surgery

scientific article published on 10 September 2007

Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.

scientific article published on 25 July 2008

Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease

scientific article

Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease

scientific article published on 06 May 2019

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

scientific article published on 29 November 2017

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

scientific article published on 2 November 2015

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

scientific article published on 01 March 2019

Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment

scientific article published on 01 February 2019

Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery: Results From the CAPACITY and ARCADIAN Studies

scientific article published on 19 February 2018

Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease

scientific article

Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants.

scientific article published on 4 April 2018

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

scientific article published on 27 March 2017

Association of brain network dynamics with plasma biomarkers in subjective memory complainers

scientific article published on 23 December 2019

Association of cerebrospinal fluid α-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers

scientific article published on 26 July 2018

Association of complement factor H Y402H gene polymorphism with Alzheimer's disease

scientific article published in September 2008

Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults

scientific article

Association of nAChR gene haplotypes with heavy alcohol use and body mass

scientific article published on 19 August 2009

Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass

scientific article published on 25 September 2008

Association of the RAGE G82S polymorphism with Alzheimer's disease

scientific article

Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease

scientific article published on 02 September 2016

Astroglial activation and altered amyloid metabolism in human repetitive concussion

scientific article published on 10 March 2017

Author Correction: Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons

scientific article published on 28 February 2020

Author response: Calcium supplementation and risk of dementia in women with cerebrovascular disease.

scientific article published in February 2017

Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid

scientific article published on 08 October 2019

Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections

scientific article

Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases

scientific article

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease

scientific article (publication date: 30 December 2010)

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

scientific article

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

scientific article

Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem

scientific article

Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster

scientific article published on 26 August 2016

Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease

scientific article

Biochemical markers in Alzheimer's disease clinical trials

scientific article published on February 2010

Biological CSF markers of Alzheimer's disease

scientific article published on January 2008

Biological correlates of clinical subgroups of Alzheimer's disease

scientific article published in January 2002

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

scientific article

Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife

scientific article published on 20 June 2016

Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease

scientific article

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

scientific article published on 2 February 2018

Biomarker-based dissection of neurodegenerative diseases

scientific article published on 16 April 2011

Biomarker-guided clustering of Alzheimer's disease clinical syndromes

scientific article published on 10 September 2019

Biomarkers for Alzheimer's disease therapeutic trials

scientific article published on 02 December 2010

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

scientific article published on July 2010

Biomarkers for Alzheimer's: the sequel of an original model

scientific article published in February 2013

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

scientific article published on 17 August 2018

Biomarkers for microglial activation in Alzheimer's disease

scientific article published on November 2011

Biomarkers for tau pathology.

scientific article published on 7 December 2018

Biomarkers in Sporadic and Familial Alzheimer's Disease

scientific article published on July 2015

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

scientific article

Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review

scholarly article by Ulla Knorr et al published July 2018 in European Neuropsychopharmacology

Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis

scientific article published in December 2009

Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood

scientific article published on 12 February 2013

Blood Biomarkers: Democratizing Alzheimer's Diagnostics

scientific article published on 01 June 2020

Blood biomarkers for brain injury in concussed professional ice hockey players.

scientific article published in June 2014

Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving

scientific article published on 7 July 2016

Blood brain barrier function in vascular dementia.

scientific article published in April 1990

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

scientific article published on 01 May 2020

Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly

scientific article published on 19 August 2013

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

scientific article published on 08 February 2017

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

scientific article published on 01 November 2018

Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study.

scientific article

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

scientific article published on April 1990

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment

scientific article

Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease

scientific article

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

scientific article published on 17 June 2011

Both total and phosphorylated tau are increased in Alzheimer's disease

scientific article published on May 2001

Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry

scientific article published on 13 January 2015

Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure

scientific article published on 25 February 2020

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

scientific article

Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor

scientific article

Brain monoaminergic and neuropeptidergic variations in human aging

scientific article published on 01 January 1996

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease

scientific article

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

scientific article published on 16 June 2015

C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning

scientific article

CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder

scientific article published on 5 November 2015

CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage

scientific article published on 27 June 2006

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

scientific article

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

scientific article

CSF Aβ42 predicts early-onset dementia in Parkinson disease

scientific article published on 18 April 2014

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

scientific article published on January 2016

CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease

scientific article (publication date: 2012)

CSF YKL-40 and GAP-43 are related to suicidal ideation in older women

scientific article published on 17 February 2017

CSF amyloid beta42 and tau levels correlate with AIDS dementia complex

scientific article published in November 2005

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.

scientific article published on 3 November 2010

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

scientific article

CSF and blood biomarkers for Parkinson's disease

scientific article published on 10 April 2019

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

scientific article published on 8 April 2016

CSF antithrombin III and disruption of the blood-brain barrier

scientific article published on 30 March 2009

CSF biomarker variability in the Alzheimer's Association quality control program

scientific article published on May 2013

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

scientific article published in July 2009

CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly

scientific article published on 7 May 2012

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics

scientific article published on 05 June 2019

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

scientific article published on 2 January 2006

CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment

scientific article

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.

scientific article published on 19 February 2013

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

scientific article

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

scientific article

CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.

scientific article published in November 2007

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

scientific article published on 27 February 2018

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

scientific article published in May 2010

CSF biomarkers: pinpointing Alzheimer pathogenesis

scientific article published on October 2009

CSF in Alzheimer's disease.

scientific article

CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment

scientific article published on 13 February 2014

CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease

scientific article published in January 2010

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects

scientific article published on 13 April 2020

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

scientific article published on 01 January 2000

CSF markers for Alzheimer's disease: Total tau, phospho-tau and Aβ42 ⬇️

scientific article published on October 1, 2003

CSF markers for incipient Alzheimer's disease

scientific article published on October 2003

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry

scientific article

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers

scientific article published on 13 December 2017

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

scientific article published on 22 October 2014

CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults

scientific article published on 28 September 2016

CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD

scientific article published on 16 May 2019

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease

scientific article published on 11 January 2018

CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment

scientific article published on 5 May 2015

CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease

scientific article published on 08 September 2016

CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults

scientific article published on 08 December 2019

CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau

scholarly article by Kristi Henjum et al published 3 November 2018 in Journal of Neuroinflammation

CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy

scientific article

CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia

scientific article published on 17 December 2019

CSF tau and β-amyloid as biomarkers for mild cognitive impairment.

scientific article

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

scientific article published in August 2002

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

scientific article

CSF α-synuclein correlates with CSF neurogranin in late-life depression

scientific article published on 31 March 2020

CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma

scientific article

CSF-methionine is elevated in psychotic patients

scientific article published on 19 March 2004

CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

scientific article published on 11 July 2017

CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study

scientific article published on 30 May 2020

Calcium supplementation and risk of dementia in women with cerebrovascular disease

scientific article published on 17 August 2016

Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue

scientific article published in July 1990

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

scientific article published in June 2009

Cardiac Surgery is Associated with Biomarker Evidence of Neuronal Damage

scientific article published on 11 March 2020

Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition

scientific article

Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort

scientific article published on 01 January 2019

Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD.

scientific article published on 24 March 2017

Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition

scientific article published in August 2015

Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers

article published in 2019

Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change

scientific article published on 20 November 2017

Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients

scientific article

Cerebral pattern of pro- and anti-inflammatory cytokines in dementias

scientific article

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET

scientific article published on 9 February 2016

Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults

scientific article published on 06 June 2020

Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease

scientific article published on 20 September 2016

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's Disease

scientific article published on 14 October 2016

Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction

scientific article published on 18 November 2015

Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type

scientific article published in January 2018

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

scientific article

Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

scientific article published on 04 May 2020

Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease

scientific article published on 01 January 2019

Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease

scientific article published on 01 January 2019

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders

article

Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years

scientific article published on 15 October 2015

Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients

scientific article published on 01 January 2020

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates

scientific article published on 28 September 2011

Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease

scientific article published on 22 January 2016

Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study

scientific article published on 18 July 2017

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

scientific article

Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium

scientific article published in September 2017

Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders

scientific article published on 19 September 2016

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study

scientific article published on 17 June 2020

Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage

scientific article published in January 2018

Cerebrospinal Fluid ‘Neuronal Thread Protein’ Comes from Serum by Passage over the Blood-Brain Barrier ⬇️

scientific article published on June 1, 1995

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

scientific article

Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy

scientific article published on 01 February 2003

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.

scientific article published on 9 October 2012

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

scientific article

Cerebrospinal fluid GAP-43 in early multiple sclerosis

Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease

scientific article published on 26 February 2007

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

scientific article published on 12 November 2008

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease

scientific article

Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?

scientific article

Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments

scientific article published on 08 May 2014

Cerebrospinal fluid analysis should be considered in patients with cognitive problems

scientific article

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

scientific article published on 27 October 2017

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

scientific article published on 11 November 2019

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

scientific article

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease

scientific article published on 18 June 2020

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition

scientific article published on 22 October 2019

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimerʼs disease ⬇️

scientific article published on December 20, 1994

Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women

scientific article

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds

scientific article published in January 2003

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

scientific article published in June 1999

Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses

scientific article published in March 2010

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

scientific article published on April 2009

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis

scientific article published on 27 October 2016

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples

scientific article published on 14 October 2013

Cerebrospinal fluid biomarkers for Alzheimer's disease

scientific article published on January 2009

Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?

scientific article published on January 2013

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

scientific article published in January 2011

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

scientific article published on 22 November 2017

Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis

scientific article published on 15 February 2019

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

scientific article published on 4 May 2016

Cerebrospinal fluid biomarkers in cardiac arrest survivors

scientific article

Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections

scientific article published on 8 March 2013

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

scientific article

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.

scientific article

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease

scientific article published on 06 May 2020

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

scientific article published on 08 March 2019

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.

scientific article published on 23 October 2018

Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study

scientific article

Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.

scientific article

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

scientific article published on 15 October 2012

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

scientific article published on 2 July 2007

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study

scientific article published on July 2013

Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis

scientific article

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

scientific article published on 21 November 2019

Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.

scientific article published on 20 March 2018

Cerebrospinal fluid insulin during non-neurological surgery

scientific article published on 10 August 2010

Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals

scientific article published on 11 July 2016

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

scientific article

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

article

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease

scientific article published in July 2004

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection

article

Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia

scientific article

Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women

scientific article published on 30 April 2016

Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis

scientific article published on 4 October 2016

Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders

scientific article published on 13 December 2019

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

scientific article published in December 2014

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

scientific article published on 01 January 2003

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

scientific article published on January 2012

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia

scientific article published on 30 January 2020

Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus

scientific article published on 25 April 2008

Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

scientific article published in November 2000

Cerebrospinal fluid markers for prediction of Alzheimer's disease ⬇️

scientific article published on November 27, 2003

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals

scientific article

Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery

scientific article

Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study

scientific article published on December 2015

Cerebrospinal fluid markers of extracellular matrix remodeling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy.

scientific article published on 17 April 2018

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

scientific article published in March 2017

Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis

scientific article published on 29 January 2016

Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype

scientific article

Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease

scientific article published in January 2011

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

scientific article published on 30 December 2016

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

scientific article published on 13 May 2011

Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls

scientific article published on 27 June 2017

Cerebrospinal fluid monoamine metabolites and atmospheric pressure.

scientific article

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age ⬇️

scientific article published on 01 March 1993

Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis

scientific article published on 27 July 2019

Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis

scientific article published on 25 May 2019

Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival

scientific article published on 6 February 2017

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

scientific article published on 27 February 2020

Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients

scientific article published on 09 July 2018

Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype

scientific article published on 26 September 2007

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

scientific article

Cerebrospinal fluid neurogranin and TREM2 in Huntington's disease.

scientific article published on 9 March 2018

Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease

scientific article

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

scientific article published on 26 April 2018

Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration

scientific article published on 25 October 2019

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

scientific article

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

scientific article published in August 1995

Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia

scientific article published in January 2002

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

scientific article published on 18 February 2012

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

scientific article

Cerebrospinal fluid protein reactions during non-neurological surgery

scientific article published on 01 April 2007

Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation

scientific article published on January 2016

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.

scientific article published on 23 February 2018

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease

scientific article

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability

scientific article

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

scientific article

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.

scientific article published on 7 October 2015

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

scientific article published on 01 September 1999

Cerebrospinal fluid tau and amyloid beta42 protein in patients with myotonic dystrophy type 1.

scientific article

Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia

scientific article

Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders

scientific article

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology

scientific article published on 01 February 2020

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

scientific article published on March 1998

Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration

article

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

scientific article published on 17 August 2016

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.

scientific article published in April 2010

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

scientific article published on 21 October 2009

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

scientific article published on 03 November 2020

Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities.

scientific article published on 3 April 2018

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele

scientific article

Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

scientific article

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.

scientific article published on 29 September 2010

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

scientific article published on 9 February 2015

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study

scientific article published on 24 October 2012

Characterization of Cerebrospinal Fluid BACE1 Species

scientific article published on 09 July 2019

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

scientific article

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease

scientific article

Characterization of proteins from human cerebrospinal fluid by a combination of preparative two-dimensional liquid-phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

scientific article

Characterization of tau in cerebrospinal fluid using mass spectrometry.

scientific article published on 20 March 2008

Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice.

scientific article published on 23 February 2011

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

scientific article published on July 2015

Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data

scientific article published on 16 September 2019

Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease?

scientific article published in November 1995

Chronic traumatic encephalopathy: fluid biomarkers

scientific article published on 01 January 2018

Circulating Aβ40 influences plasma BDNF levels and white matter integrity

Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction

scientific article published on 02 August 2019

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

scientific article

Clearance systems in the brain--implications for Alzheimer diseaser.

scientific article

Clearance systems in the brain-implications for Alzheimer disease

scientific article

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations

scientific article published in April 2001

Clinical diagnosis of Alzheimer's disease by primary care physicians and specialists

scientific article published on January 1, 1992

Clinical heterogeneity of probable Alzheimer's disease

scientific article published on April 1, 1992

Clinical mass spectrometry in neuroscience. Proteomics and peptidomics

scientific article published on July 2003

Clinical proteomics in neurodegenerative disorders

scientific article published on 13 February 2008

Clinical subgroups of the Alzheimer syndrome.

scientific article published on January 1996

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

scientific article

Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

scientific article

Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease

scientific article published in December 1998

Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms

scientific article published on 21 February 2006

Coagulation of cerebrospinal fluid--the Nonne-Froin sign.

scientific article

Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls

scientific article published on 8 May 2015

Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.

scientific article published on 9 April 2010

Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing.

scientific article

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

scientific article published on 23 July 2007

Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

scientific article

Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

scientific article

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

scientific article published on 7 June 2021

Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease

scientific article published on 17 February 2004

Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements

scientific article published on 01 November 2018

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

scientific article

Comparative proteome analysis of thalamus in MK-801-treated rats

scientific article

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

scientific article

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

scientific article published in March 2016

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

scientific article (publication date: 2012)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum

scientific article published on 10 June 2019

Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial

scientific article published on 05 March 2019

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

scientific article published on 12 April 2016

Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin

scientific article published on 23 October 2019

Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder

scientific article published on 13 November 2019

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease

scientific article published in January 2013

Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates

scientific article published on 14 September 2016

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

scientific article

Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid ⬇️

scientific article published on January 1, 1993

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease

scientific article published on 12 August 2009

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment

scientific article published on 6 November 2017

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

scientific article

Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease

scientific article published in December 1990

Consensus guidelines for lumbar puncture in patients with neurological diseases

scientific article

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

scientific article

Converging molecular pathways in human neural development and degeneration

scientific article published on 2 December 2009

Converging pathways of chromogranin and amyloid metabolism in the brain

scientific article published on January 2010

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity

scientific article published on 3 December 2003

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

scientific article

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

scientific article published on 18 January 2020

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

scholarly article published in Alzheimers Research & Therapy

Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau

scientific article published on 01 April 2019

Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury

scientific article published on 05 April 2019

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

scientific article published in February 2010

Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults

scientific article published on May 2013

Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches

scientific article published on 01 September 2019

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

scientific article published on 20 April 2016

Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease

scientific article published on 6 June 2008

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

scientific article published on 17 August 2017

Current state of Alzheimer's fluid biomarkers

scholarly article by José Luis Molinuevo et al published 1 December 2018 in Acta Neuropathologica

Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls

scholarly article by Johan Sundelöf et al published 11 August 2010 in Journal of Alzheimer's Disease

Cystatin C in cerebrospinal fluid and multiple sclerosis

scientific article

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

scientific article published on 01 May 2000

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species

scientific article published on 19 August 2018

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

scientific article published in January 2002

Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia ⬇️

scientific article published on January 1, 2003

Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder

scientific article published on July 2013

Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis

scientific article published on 27 December 2018

Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease

scientific article published in September 2001

Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus

scientific article

Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia

scientific article published on January 1996

Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease

scientific article

Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain

scientific article published on June 1999

Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.

scientific article

Delirium in dementia

scientific article

Dementia and CSF-biomarkers for Alzheimer's disease predict mortality after acute hip fracture

scientific article published on 23 October 2019

Dementia in 2010: Paving the way for Alzheimer disease drug development

scientific article published on February 2011

Dementia. It's getting better all the time

scientific article published on 01 December 1998

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

scientific article

Detection and quantification of novel tau/phospho-tau epitopes in CSF using a multiplex assay approach

Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystem

scientific article published on 01 January 1995

Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients

scientific article published on 15 November 2019

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

scientific article

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges

scientific article published on August 2012

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

scientific article published on 3 September 2012

Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease

scientific article published on 09 March 2019

Dextran- versus crystalloid-based prime in cardiac surgery: A prospective randomized pilot study

scientific article published on 14 April 2020

Diagnosis of Dementias Using Partial Least Squares Discriminant Analysis ⬇️

scientific article published on March 1, 1995

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

scientific article

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

scientific article published on 17 June 2019

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

scientific article

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease

scientific article published on 17 May 2017

Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration

scientific article published on 01 July 2020

Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry

scientific article published in April 2014

Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health

scientific article published in January 2013

Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease

scientific article published on 01 December 2005

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

scientific article published on 02 March 2020

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

scientific article published on 20 August 2020

Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma

scientific article published on 19 August 2018

Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus

scientific article published in January 2004

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging

scientific article published on December 1, 1992

Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients

scientific article published on 01 January 1996

Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects

scientific article published on May 2007

Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.

scientific article published on 22 November 2006

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

scientific article published in August 2002

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease

scientific article

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo

scientific article

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

scientific article published on 05 September 2019

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

scientific article

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis

scientific article published on 26 September 2015

Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease

scientific article published on 25 June 2020

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease

scientific article

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

scientific article

Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study.

scientific article published on 25 May 2011

Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease?

scientific article published in August 2015

Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals

scientific article published on 4 August 2009

Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

scientific article published on 3 January 2013

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

scientific article published on 01 June 2019

Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury

scientific article published on 01 September 2019

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

scientific article published on 31 October 2017

Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury

scientific article published on 08 January 2019

Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study

scholarly article by David Bäckström et al published 31 October 2018 in Neurology

Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.

scientific article published on 13 January 2016

Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease

scientific article published on January 2007

Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration

scientific article published on 01 January 2017

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

scientific article published on August 2012

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease

scientific article

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease

scientific article published on 17 April 2017

Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease

scientific article published on January 2006

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

scientific article published on 11 July 2018

Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid

scientific article published on 28 February 2017

Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men

scientific article published on 08 January 2020

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid

scientific article published on 30 July 2010

Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease

scientific article

Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology

scientific article

Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery-a randomized trial

scholarly article by Mattias Danielson et al published 27 September 2018 in Journal of Neuroinflammation

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study

scientific article published on 29 September 2017

Effects on rat thalamic proteome by acute and subchronic MK-801-treatment

scientific article

Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression

scientific article published on 23 October 2017

Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology

scientific article published on 12 October 2018

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease

scientific article published on 6 October 2011

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

scientific article

Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients

scientific article published on 30 December 2006

Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis

scientific article published on 25 October 2008

Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients

scientific article

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

scientific article published on 25 August 2005

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.

scientific article published on 5 November 2008

Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease

scientific article published on 23 June 2020

Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data

scientific article

Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease

scientific article

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease

scientific article published on 14 September 2019

Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force

scientific article published in June 2015

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.

scientific article published in July 2008

Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease

scientific article published on 01 January 2019

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

scientific article

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

scholarly article by Joakim Hertze et al published 10 September 2010 in Journal of Alzheimer's Disease

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years

scientific article

Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease

scientific article published in October 2001

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

scientific article published on 01 March 2001

Evaluation of factors of importance for clinical dementia diagnosis

scientific article

Evaluation of neprilysin sequence variation in relation to CSF β-Amyloid levels and Alzheimer disease risk

scientific article published on 15 October 2010

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

scientific article

Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study

scientific article published in January 2012

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

scholarly article by Oskar Hansson et al published April 2010 in Neurobiology of Aging

Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment

scientific article published on January 2007

Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders

scientific article published on 9 July 2013

Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient

scientific article

Evidence that the gene encoding insulin degrading enzyme influences human lifespan

scientific article

Evidence-based evaluation of magnetic resonance imaging as a diagnostic tool in dementia workup

scientific article

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment

scientific article

Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease

scientific article published on 31 January 2018

Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline

scientific article

Evolving Relevance of Neuroproteomics in Alzheimer's Disease

scientific article published in January 2017

Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

scientific article published on 20 February 2017

Exhaled endogenous particles contain lung proteins

scientific article

Expanding the cerebrospinal fluid endopeptidome

scientific article published on 03 January 2017

Explorative and targeted neuroproteomics in Alzheimer's disease

scientific article

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid

scientific article published on 27 June 2014

Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons

scientific article published on 18 October 2018

Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference.

scientific article published on 15 March 2011

Extreme stability of chitotriosidase in cerebrospinal fluid makes it a suitable marker for microglial activation in clinical trials

scientific article published in January 2012

Factors Influencing Successful Lumbar Puncture in Alzheimer Research

scientific article published on 7 September 2017

Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta

scientific article published on 12 April 2019

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain

scientific article published in January 2014

First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression

scientific article

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease

scientific article published on 08 December 2018

Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings

scientific article published on 24 July 2019

Fluid biomarkers for mild traumatic brain injury and related conditions

scientific article published on 16 September 2016

Fluid biomarkers in Alzheimer disease

scientific article

Fluid biomarkers in Alzheimer's disease - current concepts

scientific article published on 21 June 2013

Fluid markers of traumatic brain injury

scientific article published on 03 February 2015

Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis

scientific article

From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease

scientific article published on 01 January 2018

Functional mannose-binding lectin haplotype variants are associated with Alzheimer's disease

scientific article published in January 2013

Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease.

scientific article published in January 2003

Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype

scientific article published in May 2001

GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology

scientific article published on 28 September 2018

Gamma-glutamyltransferase in alcohol use disorders: Modification of decision limits in relation to treatment goals?

scientific article published in April 2010

Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study

scientific article

Gangliosides and sulfatide in cerebrospinal fluid in leukoaraiosis

scientific article published in May 1997

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

scientific article published on October 1991

Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion

scientific article published in September 2003

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

scientific article published on 29 September 2005

Genetic association of sequence variants near AGER/NOTCH4 and dementia

scientific article

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism

scientific article published in April 2004

Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function

scientific article published in January 2015

Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease

scientific article published in April 2004

Genetic variation in FOXO3 is associated with self-rated health in a population-based sample of older individuals.

scientific article published on 5 February 2018

Genetic variation in a haplotype block spanningIDE influences Alzheimer disease ⬇️

scientific article published on November 1, 2003

Genetic variation of the ghrelin signaling system in females with severe alcohol dependence

scientific article published on 25 June 2010

Genome-wide association study identifies MAPT locus influencing human plasma tau levels

scientific article published on 18 January 2017

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

scientific article published on 28 February 2017

Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls

scientific article published on 05 February 2020

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism

scientific article

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.

scientific article published on 24 August 2016

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

scientific article

Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.

scientific article published in September 1996

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium

scientific article published on 28 December 2012

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

scientific article published in May 2003

Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease

scientific article

Growth factors and neurotrophins in patients with stress-related exhaustion disorder

scientific article published on 20 August 2019

Growth-associated protein GAP-43 in the frontal cortex and in the hippocampus in Alzheimer's disease: an immunohistochemical and quantitative study.

scientific article

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

scientific article

Gut microbiome alterations in Alzheimer's disease

scientific article published on 19 October 2017

Haplotypes extending across ACE are associated with Alzheimer's disease

scientific article published in April 2003

Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF.

scientific article

Harmonized diagnostic criteria for Alzheimer's disease: recommendations

scientific article

Head size may modify the impact of white matter lesions on dementia

scientific article published on 21 March 2011

Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics

scientific article published on 27 August 2018

Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration

scientific article published on 02 October 2013

Heterogeneity of vascular dementia: mechanisms and subgroups

scientific article published on July 1993

High education may offer protection against tauopathy in patients with mild cognitive impairment

scientific article published in January 2010

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease

scientific article published on 06 June 2016

High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS.

scientific article

Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample

scientific article published on 20 May 2014

Higher Cathepsin B Levels in Plasma in Alzheimer's Disease Compared to Healthy Controls

scholarly article by Johan Sundelöf et al published 7 January 2011 in Journal of Alzheimer's Disease

Histology-Compatible MALDI Mass Spectrometry Based Imaging of Neuronal Lipids for Subsequent Immunofluorescent Staining.

scientific article

Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments

Human plasma biomarker responses to inhalational general anaesthesia without surgery

scientific article published on 11 June 2020

Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium

scientific article

Hypothalamic dysfunction in dementia

scientific article published in January 1994

Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans

scientific article (publication date: 2011)

Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.

scientific article

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

scientific article

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics

scientific article published on 31 January 2017

Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain

scientific article published on 01 May 2019

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid

scientific article

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

scientific article published on 25 June 2009

Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method

scientific article

Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry

Identification of proteins in a human pleural exudate using two-dimensional preparative liquid-phase electrophoresis and matrix-assisted laser desorption/ionization mass spectrometry

scientific article published in January 1999

Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry

scientific article

Identification of synaptic vesicle, pre- and postsynaptic proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing

scientific article published in March 1999

Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry

scientific article

Identification of tissue-specific cell death using methylation patterns of circulating DNA

scientific article published on 14 March 2016

Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers

scientific article published on 13 March 2013

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.

scientific article

Imatinib treatment and Aβ42 in humans.

scientific article

Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age

scientific article published on 01 January 1996

Immunomodulating and anti-inflammatory properties of the sympatholytic compound 6-hydroxydopamine

scientific article published on 01 December 1994

Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio

scientific article published in September 2015

Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease

scientific article

Impaired synaptic function is linked to cognition in Parkinson's disease

scientific article published on 31 August 2017

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

scientific article published on January 2017

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

scientific article

Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome.

scientific article published on 3 October 2007

Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia

scientific article published on 19 June 2017

Increased CSF biomarkers of angiogenesis in Parkinson disease

scientific article published on 28 October 2015

Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers

scientific article (publication date: 2013)

Increased CSF neurogranin concentration is specific to Alzheimer disease

scientific article published on 29 January 2016

Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease

scientific article published on 11 March 2008

Increased CSF/serum albumin ratio: a recurrent finding in violent offenders

scientific article

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.

scientific article published on 26 August 2015

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

scientific article published on May 2016

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

scientific article

Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment

scientific article

Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42

scientific article published on 08 March 2019

Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia

scientific article published in January 2002

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

scientific article published on 7 March 2016

Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

scientific article published on 5 December 2016

Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment

scientific article published on 14 October 2014

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease

scientific article published on 01 September 2004

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease

scientific article

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

article

Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos

scientific article

Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications

scientific article

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia

scientific article published on 01 March 2002

Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment

scientific article published on 13 September 2005

Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study

scientific article

Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later

scientific article

Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.

scientific article published on 16 August 2016

Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease

scientific article

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

scholarly article by Nicholas J Ashton et al published 9 January 2019 in Acta neuropathologica communications

Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease.

scientific article published in November 1995

Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis ⬇️

scientific article published on 01 October 2003

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome

scientific article published on 2 November 2005

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia

scientific article

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease

scientific article

Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

scientific article published on 28 February 2018

Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition

scientific article published on 8 May 2017

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease

scientific article

Influence of the apolipoprotein E epsilon4 allele on human embryonic development.

scientific article published in May 2002

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury

scientific article published in November 2006

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

scientific article

Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers

scientific article

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults

scientific article published on 12 April 2016

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

scientific article published on May 2010

Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals

scientific article

Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women

scientific article published on 17 October 2011

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury

scientific article published on 02 June 2020

Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.

scientific article published on January 1990

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

scientific article published in November 2007

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia

scientific article published in July 1999

Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients

scientific article published on 01 January 1997

Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity

scientific article published on 16 August 2017

Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease

scientific article

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

scientific article published on 12 June 2013

Intrathecal inflammation precedes development of Alzheimer's disease

scientific article

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement

scientific article

Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia

scientific article published on 01 November 2000

Intrathecal synthesis of immunoglobulin G in vascular dementia

scientific article published on 01 February 1990

Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease

scientific article published on November 1990

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

scientific article published on 31 January 2013

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?

scientific article

Is there a CSF biomarker profile related to depression in elderly women?

scientific article published on 04 February 2010

KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD

scientific article published on 13 March 2019

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease

scientific article published on 01 August 2007

Kinesin light chain 1 gene haplotypes in three conformational diseases.

scientific article published on 13 November 2009

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

scientific article published in November 2001

Laboratory testing for lyme neuroborreliosis

scientific article published on 01 January 2015

Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease

scientific article published in June 2001

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease

scientific article

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study

scientific article published on 22 December 2011

Levels of ADAM10 are reduced in Alzheimer's disease CSF

scientific article published on 25 July 2018

Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment

scientific article

Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants

scientific article

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease

scientific article

Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia

scientific article published in March 2001

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

scientific article published on 16 February 2016

Longitudinal Performance of Plasma Neurofilament Light and Tau in Professional Fighters: The Professional Fighters Brain Health Study

article

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

scientific article published on 09 October 2015

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

scientific article

Longitudinal change in regional brain volumes with exposure to repetitive head impacts

scientific article published on 23 December 2019

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease

scholarly article by Philip S J Weston et al published 20 February 2019 in Alzheimers Research & Therapy

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease.

scientific article published in January 2012

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

scientific article published on 6 April 2007

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease

scientific article published on 17 July 2009

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease

Longstanding psychological stress in relation to biomarkers of neuronal dysfunction in cerebrospinal fluid: a 25-year follow-up study in women

scientific article published on 27 February 2019

Losing the identity of a hockey player: the long-term effects of concussions

scientific article published on 11 May 2020

Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.

scientific article

Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke

scientific article published on 14 June 2016

Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?

scientific article

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

scientific article published in November 2001

Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study

scientific article published on 22 August 2012

Low frequency of post-lumbar puncture headache in demented patients

scientific article published on 01 September 1993

Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients

scientific article published on 3 June 2010

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease

scientific article published on 02 January 2020

Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.

scientific article published in January 2006

Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.

scientific article published on 2 November 2017

Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD.

scientific article published on 12 September 2009

Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder

scientific article published on May 2012

Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years

scientific article

Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults

scientific article published on 02 March 2020

Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease

scientific article published on 08 October 2013

MS risk genes are transcriptionally regulated in CSF leukocytes at relapse

scientific article published on 20 August 2012

Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease

scientific article published on January 2009

Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.

scientific article published in July 2004

Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes

scientific article published on 5 May 2017

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

scientific article published on 3 October 2017

Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease

scientific article published on 15 April 2019

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

scientific article

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease

scientific article published on 24 April 2010

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

scientific article

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.

scientific article published on 28 November 2011

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

scientific article published in September 2003

Measurement of apolipoprotein E (apoE) in cerebrospinal fluid

scientific article published on 01 April 2000

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

scientific article

Measuring longitudinal cognition: Individual tests versus composites

scientific article published on 11 January 2019

Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes

scientific article published in July 2009

Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42.

scientific article

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease

scientific article published on 01 January 2014

Methylenetetrahydrofolate reductase genetic polymorphisms in patients with cataract

scientific article published in November 2005

Methylenetetrahydrofolate reductase genetic polymorphisms in patients with primary open-angle glaucoma

scientific article published on 01 June 2007

Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.

scientific article published in January 2013

Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging

scientific article

Mid-life adiposity factors relate to blood-brain barrier integrity in late life

scientific article published on 07 November 2007

Mid-life dementia risk scores as a predictor of CSF biomarker response to simvastatin therapy in asymptomatic adults at risk for Alzheimer's disease: The ESPRIT study

scientific article published in July 2010

Midlife Stress in Relation to Late-Life Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: A 25-Year Follow-Up Study

scientific article published on 24 August 2018

Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

scientific article

Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences

scientific article published on 05 June 2020

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

scientific article published in September 2004

Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women

scholarly article by Per Johansson et al published 5 August 2011 in Clinical Endocrinology

Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration

scientific article published on 19 December 2017

Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics

scientific article published on September 1999

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease.

scientific article published on 6 February 2018

Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study

scientific article published on 26 September 2019

Monitoring concussion in a knocked-out boxer by CSF biomarker analysis.

scientific article published on 13 May 2014

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

scientific article published on 27 October 2017

Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury

scientific article published in June 2009

Monitoring of β-amyloid dynamics after human traumatic brain injury

scientific article published on 4 October 2013

Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.

scientific article

Monocyte and microglial activation in patients with mood-stabilized bipolar disorder

scientific article published on July 2015

Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment

scientific article published on 10 May 2012

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

scientific article published in December 2007

Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals Aβ Aggregation Dependent Anionic Lipid Accumulations and Metabolism

scientific article published on 19 June 2018

Multiplexing and multivariate analysis in neurodegeneration

scientific article published on 25 February 2012

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease

scientific article published on 15 April 2016

NFL blood levels are moderated by subconcussive impacts in a cohort of college football players

scientific article published on 11 January 2019

NFL is a marker of treatment response in children with SMA treated with nusinersen

scientific article published on 23 May 2019

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

scientific article published in April 2018

Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury

scientific article published on 19 September 2016

Neurochemical aftermath of amateur boxing

scientific article published in September 2006

Neurochemical dissection of synaptic pathology in Alzheimer's disease.

scientific article published in March 1998

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

scientific article published on 16 June 2020

Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation

scientific article published on 3 May 2014

Neurochemical measures co-vary with personality traits: forensic psychiatric findings replicated in a general population sample

scientific article published on 8 July 2010

Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia

scientific article published on 29 June 2018

Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission

scientific article

Neuroendocrine Assessment of Serotonergic, Dopaminergic, and Noradrenergic Functions in Alcohol-Dependent Individuals

scientific article published on 28 July 2011

Neurofilament Light in Serum and Cerebrospinal Fluid of Hip Fracture Patients with Delirium

scientific article published on 06 December 2018

Neurofilament Protein and Antineurofilament Antibodies Following Traumatic Brain Injury-Reply

scientific article published on 30 January 2017

Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke

scientific article published on 29 December 2018

Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

scientific article published on 18 July 2018

Neurofilament light and tau as blood biomarkers for sports-related concussion.

scientific article published on 13 April 2018

Neurofilament light chain as a biomarker in neurological disorders

scientific article published on 09 April 2019

Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy

scientific article published on 13 June 2018

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy

article

Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis

scientific article published on 6 March 2017

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

scientific article published on 09 June 2017

Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity

scientific article published on 24 April 2020

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.

scientific article published on 02 August 2016

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice

scientific article published on 26 October 2017

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

scientific article

Neurofilament light protein in blood predicts regional atrophy in Huntington disease

scientific article

Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.

scientific article

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

scientific article published in November 2001

Neurofilament protein levels in CSF are increased in dementia.

scientific article published in March 1999

Neurofilament relates to white matter microstructure in older adults

scientific article published on 28 June 2018

Neurofilament-Light in Former Athletes: A Potential Biomarker of Neurodegeneration and Progression

scientific article published on 13 April 2020

Neurofilaments as biomarkers in neurological disorders

article by Michael Khalil et al published 31 August 2018 in Nature Reviews Neurology

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease

scientific article published on 8 December 2016

Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep

scientific article published on 19 December 2019

Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox

scientific article published on 01 November 2015

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease

scientific article

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke

scientific article published on 30 August 2017

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

scientific article published on 9 March 2018

Neurogranin as a predictor of memory and executive function decline in MCI patients

scientific article published on 2 February 2018

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

scientific article published on 25 September 2010

Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers

scientific article published on 22 September 2017

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease

scientific article published on 19 December 2010

Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy

scientific article

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

scientific article

Neuroinflammatory markers associate with cognitive decline after major surgery: Findings of an explorative study

scientific article published on 25 January 2020

Neurological assessment and its relationship to CSF biomarkers in amateur boxers

scientific article

Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?

scientific article published on 01 January 1994

Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke

scientific article

No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease

scientific article published in November 2002

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

scholarly article by Kaj Blennow et al published 11 August 2000 in Journal of Neural Transmission

No association of LOXL1 gene polymorphisms with Alzheimer's disease.

scientific article published on 11 May 2011

No association of VEGF polymorphims with Alzheimer's disease.

scientific article published on 20 October 2009

No association of salivary total tau concentration with Alzheimer's disease

scientific article published on 20 June 2018

No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion

scientific article published in PLoS ONE

No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.

scientific article published on 07 September 2016

No evident neuronal damage after electroconvulsive therapy

scientific article published on 01 October 2000

No neurochemical evidence for brain injury caused by heading in soccer

scientific article published on 11 May 2007

No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons

scientific article published in April 2011

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization

scientific article published on 20 September 2016

Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity

scientific article published on 14 January 2014

Non-neurological surgery results in a neurochemical stress response

scientific article published on 4 February 2008

Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke

scientific article published in October 2001

Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report

scientific article

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

scientific article published on January 2011

Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

scientific article

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

scientific article

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.

scientific article published on 13 December 2018

Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract.

scientific article published on 12 January 2010

Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study

scientific article published on 10 November 2017

Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma

scientific article published on 8 March 2013

One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis

scientific article published in January 2001

Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β.

scientific article published on 24 September 2012

Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects

scientific article published on 29 February 2016

Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's

scientific article

P3-071: Mass spectrometric characterization of tau in cerebrospinal fluid

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

scientific article published in January 2010

Parenteral administration of GM1 ganglioside to presenile Alzheimer patients

scientific article published in January 1990

Pathogenetic basis of vascular dementia.

scientific article published on January 1991

Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease

scientific article published on 21 September 2016

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS

scientific article

Peptidomic analysis of cartilage and subchondral bone in OA patients

scientific article published on 27 February 2019

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

scientific article published on 11 September 2015

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status

scientific article published on 24 June 2019

Performance on a pattern separation task by Alzheimer's patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels

scientific article

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

scientific article

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg

scientific article published on 28 February 2020

Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease

scientific article published on 6 March 2017

Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders

scientific article

Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study

scientific article published in November 2005

Pinpointing plaques with PIB.

scientific article published in July 2006

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

scientific article published on 07 July 2016

Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study

scientific article published on 20 March 2010

Plasma Abeta in Alzheimer's disease--up or down?

scientific article published in August 2006

Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.

scientific article published on 24 March 2018

Plasma BDNF levels vary in relation to body weight in females

scientific article (publication date: 2012)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

scientific article published on 22 November 2015

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia

scientific article published on 02 March 2020

Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease

scientific article published on 25 May 2017

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

scientific article published on 18 May 2019

Plasma amyloid-β in patients with Tangier disease

scientific article published in January 2013

Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures

scientific article published on 10 June 2019

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

scientific article published on 29 August 2007

Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort

scientific article published on 16 August 2017

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

scientific article published on 11 December 2019

Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease

scientific article published on 7 January 2017

Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins

scientific article published in March 2004

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

scientific article published on 28 November 2019

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease

scientific article published on 28 July 2018

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals

scientific article published on 27 September 2019

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease

scientific article published on 10 October 2019

Plasma neurofilament light chain concentration in the inherited peripheral neuropathies

scientific article published on 10 January 2018

Plasma neurofilament light chain concentration is increased in anorexia nervosa

scientific article published on 01 August 2019

Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study

scientific article published on 01 June 2020

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.

scientific article published in June 2017

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

scientific article published on February 2016

Plasma pyroglutamate-modified amyloid beta differentiates amyloid pathology

scientific article published on 30 April 2020

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease

scientific article published on 28 June 2019

Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease

scientific article published on 04 December 2019

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Plasma tau levels in Alzheimer's disease

scientific article published on 28 March 2013

Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia

scientific article

Plasma β-amyloid in Alzheimer's disease and vascular disease

scientific article published on 31 May 2016

Platelet monoamine oxidase B in family history positive and family history negative type 1 alcohol-dependent subjects

scientific article published in November 2002

Platelet monoamine oxidase-B activity in type 1 alcohol-dependent subjects in sustained full remission

scientific article published in July 2002

Pleiotropy in the Presence of Allelic Heterogeneity: Alternative Genetic Models for the Influence of APOE on Serum LDL, CSF Amyloid-β42, and Dementia ⬇️

scientific article published on January 1, 2010

Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease

scientific article published on 4 September 2017

Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults

scientific article

Postoperative delirium is associated with increased plasma neurofilament light

scientific article published on 01 January 2020

Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability

scientific article published on 30 June 2015

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

scientific article published in March 2016

Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium

scientific article published on 20 September 2016

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

scientific article published on 10 January 2017

Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease

scientific article published in January 2015

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

scientific article published on 23 October 2017

Predicting MCI outcome with clinically available MRI and CSF biomarkers

scientific article

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

scientific article published on 16 February 2017

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

scientific article published on 24 September 2007

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

scientific article published on 27 February 2013

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides

scientific article

Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment

scientific article published on 2 November 2010

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

scientific article published on 19 March 2007

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

scientific article published on 06 January 2020

Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Piteå Dementia Project

scientific article published in January 1999

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

scientific article published on 10 June 2009

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

scientific article published on May 2015

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.

scientific article published on 13 April 2018

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

scientific article published on 27 March 2018

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

scientific article published on 08 May 2019

Processing of neuropeptide Y and somatostatin in human cerebrospinal fluid as monitored by radioimmunoassay and mass spectrometry

scientific article

Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

scientific article

Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

scientific article published on August 2012

Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations

scientific article published on 3 November 2011

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies

scientific article published on 03 October 2019

Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease

scientific article published on 31 August 2015

Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio

scientific article published in January 1993

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

scientific article published in January 1993

Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production

scientific article published in January 1993

Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats

scientific article published on 22 February 2007

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

scientific article published in April 2002

Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electrophoresis approach prior to mass spectrometry

scientific article

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

scientific article

Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update

scientific article published on 25 September 2017

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease ⬇️

scientific article published on October 21, 2003

Proteomics profiling of single organs from individual adult zebrafish

scientific article published in June 2010

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases

scientific article published on January 2009

Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia.

scientific article published on 2 July 2010

Publisher Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

scholarly article by Kina Höglund et al published 19 November 2018 in Translational Psychiatry

Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics

scientific article published in March 2000

Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease

scientific article

Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology

scientific article published in 2019

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

scientific article

Quality Assessment of 25(OH)D, Insulin, Total Cholesterol, Triglycerides, and Potassium in 40-Year-Old Frozen Serum

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

scientific article published in May 2000

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases

Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid ⬇️

scientific article published on March 11, 1991

Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels

scientific article published on 22 December 2005

Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum

scientific article published on 08 January 2013

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype

scientific article published on 7 May 2009

Rarity of the Alzheimer disease-protective APP A673T variant in the United States

scientific article

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

scientific article

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

scientific article

Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head

scientific article published in February 2003

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

scientific article

Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.

scientific article published on 19 August 2016

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

scientific article published on 19 January 2009

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

scientific article

Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease

scientific article

Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease

scientific article

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

scientific article published on 8 November 2013

Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.

scientific article published in January 2009

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.

scientific article published on 10 May 2018

Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study

scientific article published on 18 April 2019

Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia

scientific article

Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia

scientific article published on 01 December 1999

Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.

scientific article published in January 2000

Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia

scientific article published in May 2002

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

scientific article published on 31 August 2016

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

scientific article published on August 2012

Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.

scientific article published in November 1994

Relationship between CSF biomarkers and language fluency in asymptomatic middle-aged adults at increased risk for Alzheimer's disease: The ESPRIT study

scientific article published in July 2010

Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus

scientific article

Relationship between mental impairment and HPA axis activity in dementia disorders.

scientific article published in September 1994

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease

scientific article published on 01 April 2019

Removal of sodium dodecyl sulfate from protein samples prior to matrix-assisted laser desorption/ionization mass spectrometry

scientific article

Repeated lumbar punctures within 3 days may affect CSF biomarker levels

scientific article published on 13 December 2019

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

scientific article

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

scientific article published on 04 November 2019

Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study

scientific article

Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation

scientific article published on January 2001

Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.

scientific article published on 21 July 2015

S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment

scientific article published on 10 November 2010

S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies

scientific article published on 01 January 2018

SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration

scientific article published on 18 August 2011

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease

scientific article

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

scientific article

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

scientific article published on 30 July 2008

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

scientific article

Salivary Biomarkers for Alzheimer's Disease and Related Disorders

scientific article published on 12 December 2019

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid

scientific article

Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease

scientific article

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest

scientific article published on 13 April 2019

Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production

scientific article

Semagacestat's fall: where next for AD therapies?

scientific article

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

scientific article published in October 1999

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain

scientific article published in June 2005

Sequence variation in SORL1 and dementia risk in Swedes

scientific article

Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.

scientific article

Serotonergic, noradrenergic, and dopaminergic measures in suicide brains

scientific article published in May 1997

Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load

scientific article published on 06 June 2020

Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke

scientific article published on 28 May 2019

Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest

scientific article published on 01 January 2019

Serum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries

scientific article published on 23 April 2019

Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study

scientific article published on 19 August 2016

Serum Neurofilament Light in American Football Athletes Over the Course of a Season

scientific article published on 23 December 2015

Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas

scientific article published on 20 September 2019

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

scientific article published on 16 May 2017

Serum SNTF Increases in Concussed Professional Ice Hockey Players and Relates to the Severity of Postconcussion Symptoms

scientific article

Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players

scientific article published on 26 January 2015

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

scholarly article by Per Johansson et al published September 2013 in Psychoneuroendocrinology

Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability.

scientific article

Serum erythropoietin and outcome after ischaemic stroke: a prospective study

scientific article published on 25 February 2016

Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage

scientific article published on 29 March 2007

Serum levels of LIGHT in MS

article by Clas Malmeström et al published 4 October 2012 in Multiple Sclerosis Journal

Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury

scientific article published on 14 January 2008

Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports

scientific article published on 12 April 2017

Serum neurofilament light chain in progressive supranuclear palsy

scientific article published on 12 June 2018

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

scientific article published on 31 August 2016

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration

scientific article published on 25 October 2017

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

scientific article

Serum tau and neurological outcome in cardiac arrest.

scientific article published on 5 October 2017

Serum tau concentration after diving - an observational pilot study

scientific article published on 01 June 2019

Serum visinin-like protein-1 in concussed professional ice hockey players

scientific article published on 8 May 2015

Sex difference in CHI3L1 expression levels in human brain aging and in Alzheimer's disease

scientific article published on 24 June 2019

Sex differences in the genetic predictors of Alzheimer's pathology

scientific article published on 01 September 2019

Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau

scientific article published on 01 August 2018

Sex-specific genetic predictors of Alzheimer's disease biomarkers

scientific article published on 02 July 2018

Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice using Multimodal MALDI Imaging Mass Spectrometry.

scientific article published on 12 April 2018

Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?

scientific article

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease

scientific article published on January 1, 1992

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

scientific article published on 24 November 2004

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid

scientific article

Sleep Deprivation and CSF Biomarkers for Alzheimer Disease

scientific article published on 7 February 2018

Sleep deprivation and plasma biomarkers for Alzheimer's disease

scientific article published on 12 February 2019

Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau

scientific article published on 21 February 2019

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

article

Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4.

scientific article published on 22 June 2018

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

scientific article

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression

scientific article published on 26 July 2019

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

scientific article

Spatial Chemometrics and Comprehensive Chemical Imaging based Molecular Histopathology Delineates Anatomical Heterogeneity at Single Pixel Resolution

Specific Triazine Herbicides Induce Amyloid-β42 Production

scientific article

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

scientific article

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

scientific article

State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression

scientific article published on 9 August 2016

Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease

scientific article published on 4 June 2005

Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia

scientific article published in October 1996

Steroid-responsive encephalitis in Covid-19 disease

scientific article published on 17 May 2020

Steroid-responsive encephalitis in Covid-19 disease

scientific article published on 17 April 2020

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

scientific article

Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains

scientific article published in January 2005

Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins

scientific article

Subcortical vascular dementia biomarker pattern in mild cognitive impairment.

scientific article published on 27 October 2009

Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.

scientific article published in November 2005

Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis

scientific article published on 25 August 2017

Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

scientific article published on February 1, 1992

Sustained release of neuron-specific enolase to serum in amateur boxers

scientific article published in August 2009

Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia

scientific article published on 01 January 2000

Synaptic degeneration in thalamus in schizophrenia

scientific article published in September 1996

Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.

scientific article published in January 1996

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.

scientific article published on 15 January 2018

Synaptic retrogenesis and amyloid-beta in Alzheimer's disease

scientific article

Synaptic vesicle protein 2A as a potential biomarker in synaptopathies

scientific article published on 20 February 2019

Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias

scientific article published on 06 January 2020

Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?

scientific article published in February 1996

TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease

scientific article

TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD.

scientific article published in June 2000

TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly

scientific article published on April 2011

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype

scientific article published in January 2001

Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.

scientific article

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device

scientific article published on 07 July 2016

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta

scientific article published on April 2008

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry

scientific article published on 25 February 2016

Targeting synaptic pathology with a novel affinity mass spectrometry approach

scientific article published on 27 June 2014

Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.

scientific article published in October 2001

Tau as a molecular biomarker in cerebrospinal fluid and plasma

article published in 2014

Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification

scientific article

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

scientific article published on March 2017

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?

scientific article

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

scientific article published in December 1995

Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study

scientific article published on 9 August 2012

Tau, s-100 calcium-binding protein B, and neuron-specific enolase as biomarkers of concussion-reply

scientific article published in July 2014

Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage

scientific article published on 02 March 2020

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid

scientific article published on 7 November 2015

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

scientific article published on 20 January 2012

The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data

The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort

scientific article

The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.

scientific article published on 5 October 2008

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

scientific article published on July 2011

The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans

scientific article published on July 2015

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

scientific article

The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease

scientific article published on 29 November 2016

The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up

scientific article

The Influence of Metabolic Syndrome on Simvastatin Therapy In Asymptomatic Adults at Risk for Alzheimer's Disease: The ESPRIT Study

scientific article published in July 2010

The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis

scientific article published on 06 August 2011

The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association

scientific article published on 11 September 2007

The Past and the Future of Alzheimer's Disease Fluid Biomarkers.

scientific article published in January 2018

The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations

scientific article

The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease

scientific article

The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain

scholarly article by Yohanna Eriksson et al published 10 July 2018 in Cell Death and Disease

The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease

scientific article published on October 1996

The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease

scientific article published in April 1997

The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee

scientific article

The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase

scientific article published on 26 August 2009

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease

scientific article

The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism

scientific article

The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients

scientific article published on 14 August 2008

The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.

scientific article published in June 2006

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

scientific article published on 8 April 2014

The clinical diagnosis of vascular dementia

scientific article published on May 1994

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

scientific article published on 02 March 2020

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

scientific article published on 20 August 2014

The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply

scientific article published on 11 October 2016

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia

scientific article published in January 2011

The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution

scientific article published on 01 April 1996

The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth

scientific article published on 21 January 2015

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

scientific article

The effects of different familial Alzheimer's disease mutations on APP processing in vivo

scientific article published on 16 February 2017

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

scientific article published on 24 October 2007

The future of blood-based biomarkers for Alzheimer's disease

scientific article

The glial marker YKL-40 is decreased in synucleinopathies

scientific article published on 11 July 2013

The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia

scientific article published on 01 August 1999

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease

scholarly article by Nicholas M Vogt et al published 22 December 2018 in Alzheimers Research & Therapy

The immune response of the human brain to abdominal surgery

scientific article

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018

The impact of social networks and APOE ε4 on dementia among older adults: tests of possible interactions

scientific article published on 27 December 2018

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology

scientific article (publication date: 26 April 2017)

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease

scientific article published on 22 September 2018

The link between cholesterol and Alzheimer's disease

scientific article

The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study

scientific article

The neurochemistry of vascular dementia.

scientific article published on May 1994

The neuropathology and neurobiology of traumatic brain injury

scientific article published on December 2012

The new cholesterol controversy - a little bit of history repeating?

scientific article published in January 2006

The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease

scientific article published on 7 February 2018

The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid

scientific article published on 23 November 2019

The past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events

scientific article

The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium

scientific article published on July 2008

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

scientific article published on 03 October 2016

The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease

scientific article published on 20 July 2018

The recency ratio is associated with reduced CSF glutamate in late-life depression

scientific article

The recency ratio is related to CSF amyloid beta 1-42 levels in MCI-AD

scientific article published on 10 December 2018

The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals

scientific article published on March 2015

The relationship between cerebrospinal fluid biomarkers and depression in elderly women

scientific article published in October 2007

The role of clusterin in amyloid-β-associated neurodegeneration

scientific article

The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.

scientific article published in July 1999

The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease.

scientific article published on 24 September 2009

The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains

scientific article

The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small

scientific article

The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease

scientific journal article

The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's disease

scientific article published on 01 June 2005

The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion

scientific article published in December 2002

The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C ⬇️

scientific article published on May 1, 2003

The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials

scientific article published on 12 June 2017

There is a strong evidence that professional boxing results in chronic brain damage. The more head punches during a boxer's career, the bigger is the risk

scientific article

Thrombocytopenia in early alcohol withdrawal is associated with development of delirium tremens or seizures

scientific article

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

scientific article

Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair

scientific article

Towards compendia of negative genetic association studies: an example for Alzheimer disease

scientific article published on 8 December 2005

Trabalho de consenso de força-tarefa da WFSBP sobre marcadores biológicos das demências: contribuição da análise do LCR e do sangue para o diagnóstico precoce e diferencial das demências

Transcobalamin polymorphism and homocysteine

scientific article published in December 2001

Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease.

scientific article published on 20 January 2004

Transient increase in CSF GAP-43 concentration after ischemic stroke

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

scientific article published in January 2001

Transient inflammation in neurogenic regions after irradiation of the developing brain

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link

scientific article published on 30 January 2018

Traumatic brain injuries.

scientific article published on 17 November 2016

Treatment of Alzheimer's disease with clioquinol

scientific article

Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein

scientific article published in January 2003

Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP

Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid

scientific article published on 13 July 2019

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

scientific article

Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.

scientific article

Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease

scientific article

Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts ⬇️

scientific article

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

scientific article

Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease

scientific article published on 01 January 2019

Unaltered plasma levels of beta-amyloid(1-40) and beta-amyloid(1-42) upon stimulation of human platelets

scientific article

Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.

scientific article

Update on biomarkers for amyloid pathology in Alzheimer's disease

scientific article published on 15 June 2018

Update on fluid biomarkers for concussion

scientific article published on 18 February 2016

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

scientific article

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

scientific article

Use of CSF biomarkers in Alzheimer's disease clinical trials.

scientific article published in April 2009

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease

scientific article

Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.

scientific article published in August 2006

Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).

scientific article

Validation of a new assay for α-synuclein detection in cerebrospinal fluid

scientific article published on 30 July 2016

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

scientific article

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

scientific article published on 15 May 2015

Validity and Normative Data for the Biber Figure Learning Test: A Visual Supraspan Memory Measure

scientific article published on 01 May 2018

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.

scientific article published in July 2004

Variability in the kinesin light chain 1 gene may influence risk of age-related cataract.

scientific article published on 27 June 2007

Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease

scientific article published on 18 March 2004

Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus

scientific article published in March 2007

Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men

scientific article published on April 1, 1992

Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment

scientific article

Vitamin D supplementation and neurofilament light chain in multiple sclerosis

scientific article published on 12 November 2018

White matter changes in familial Alzheimer's disease

scientific article published on 12 March 2015

White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia--diagnostic and pathogenetic aspects

scientific article published on 01 December 1989

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.

scientific article published on 15 March 2018

White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors

scientific article published on March 1991

Withdrawn: Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer's disease

scientific article published on 28 September 2016

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis

scientific article published on 22 January 2016

Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid

scientific article

[Alzheimer's disease - the most common cause of dementia]

scientific article published on 09 March 2020

[Automated cerebrospinal fluid cell count. A valuable contribution to diagnostics of brain diseases]

scientific article published on 01 October 2011

[Biomarkers in cerebrospinal fluid and blood in memory complaints].

scientific article

[CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice]

scientific article published on 01 May 2001

[Exercise and weight loss does not reduce cardiovascular risk in type 2 diabetes]

[Guidelines for brain concussion in sports--how are they to be applied in boxing?].

scientific article published in May 2007

[New discoveries on Alzheimer disease: new biochemical markers can hopefully improve diagnosis]

scientific article published in January 2000

[New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].

scientific article

[The concept of dementia--does it enlighten or confuse?]

scientific article published on 01 March 1993

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

scientific article

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

scientific article

β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage

scientific article published on 17 November 2014

Paulina is supported by:

About Paulina

Help